FDA Says No to Weight-Loss Combo Drug Contrave - ABC News
Links shared publicly online about this topic.
- 529total visits
FDA Says No to Weight-Loss Combo Drug Contrave - ABC News
View full resource at abcnews.go.com
Tags: Obesity Medication, Antidepressant, Drug, Smoking Cessation Medication, FDA, Contrave, News
Most Recently Shared on February 6, 2011 at 9:37 am By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/gAs5L8
FDA Says No to Weight-Loss Combo Drug - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risks, the company said.” View full resource at qualitypointtech.net
Most Recently Shared on February 1, 2011 at 6:01 pm By:
FDA Says No to Weight-Loss Combo Drug: (MedPage Today) -- A pill combining bupropion and naltrexone for weight los... http://bit.ly/eKfeef
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:50 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/hL8N7y
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:39 pm By:
Evelyn Tribole Nutritionist, Dietitian, and Active Health Library
FDA Says No to Weight-Loss Combo Drug, Contrave, which consists of bupropion and naltrexone. http://bit.ly/g6SOkp
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:13 pm By:
FDA says no to weight-loss combo drug: http://bit.ly/eTFDFC
Combo of old drugs offers new hope in obesity fight - CNN.com
cnn.com — “Diet drugs have had a rough year in 2010. In October, the U.S. Food and Drug Administration (FDA) nixed not one but two new weight-loss drugs, lorcaserin and Qnexa, because of possible links to cancer (lorcaserin) and heart problems (Qnexa).” View full resource at cnn.com
Most Recently Shared on December 10, 2010 at 3:34 pm By:
Hisham Rana, MD Doctor and Physician
News: Combo of old drugs in Contrave offers new hope in obesity fight http://bit.ly/hrhZCM - Not so fast--final vote is in January. #health
Advertisement
